These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13348662)

  • 1. Prevention of psychological effects of d-lysergic acid diethylamide (LSD 25) by its 2-brom derivative (BOL 148).
    GINZEL KH; MAYER-GROSS W
    Nature; 1956 Jul; 178(4526):210. PubMed ID: 13348662
    [No Abstract]   [Full Text] [Related]  

  • 2. New blocking agent against the development of LSD-25 psychosis.
    FABING HD
    Science; 1955 Feb; 121(3137):208-10. PubMed ID: 13237971
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental compound mer-17 (frenquel): a new blocking agent against the development of LSD-25 psychosis.
    FABING HD
    Trans Am Neurol Assoc; 1955-1956; (80th Meeting):83-5. PubMed ID: 13312008
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicotinic acid modified lysergic acid diethylamide psychosis.
    AGNEW N; HOFFER A
    J Ment Sci; 1955 Jan; 101(422):12-27. PubMed ID: 14368207
    [No Abstract]   [Full Text] [Related]  

  • 5. Model psychoses induced by LSD-25 in normals. II. Rorschach test findings.
    BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E
    AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):612-8. PubMed ID: 13325990
    [No Abstract]   [Full Text] [Related]  

  • 6. Model psychoses induced by LSD-25 in normals. I. Psychophysiological investigations, with special reference to the mechanism of the paranoid reaction.
    BERCEL NA; TRAVIS LE; OLINGER LB; DREIKURS E
    AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):588-611. PubMed ID: 13325989
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of mescaline and lysergic acid (d-LSD-25).
    HOCH PH; CATTELL JP; PENNES HH
    Am J Psychiatry; 1952 Feb; 108(8):579-84. PubMed ID: 14903183
    [No Abstract]   [Full Text] [Related]  

  • 8. Lysergic acid diethylamide; a clinical-psychological study.
    SAVAGE C
    Am J Psychiatry; 1952 Jun; 108(12):896-900. PubMed ID: 14923903
    [No Abstract]   [Full Text] [Related]  

  • 9. [Body scheme disorders in lysergic acid diethylamide].
    ARNOLD OH; HOFF H
    Wien Z Nervenheilkd Grenzgeb; 1953; 6(4):259-74. PubMed ID: 13078611
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade by brom-lysergic-acid-diethylamide (BOL) of the potentiating action of serotonin and reserpine on hexobarbital hypnosis.
    SALMOIRAGHI GC; SOLLERO L; PAGE IH
    J Pharmacol Exp Ther; 1956 Jun; 117(2):166-8. PubMed ID: 13332558
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychological and biochemical effects of lysergic acid diethylamide.
    MAYER-GROSS W; McADAM W; WALKER JW
    Nature; 1951 Nov; 168(4280):827-8. PubMed ID: 14890764
    [No Abstract]   [Full Text] [Related]  

  • 13. THE EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO LYSERGIC ACID TARTRATE (BOL-148) ON SPECIFIC CHOLINESTERASE AND MONOAMINE OXIDASE OF RAT LIVER AS POSSIBLE FACTORS IN THE MECHANISM OF HALLUCINATION. A HISTOCHEMICAL STUDY.
    NANDY K; SHANTHAVEERAPPA TR; BOURNE GH
    Acta Histochem; 1964 Apr; 17():259-67. PubMed ID: 14190338
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hallucinations caused by lysergic acid in bilateral enucleation].
    ALEMA G
    Riv Neurol; 1952; 22(5):720-33. PubMed ID: 13056494
    [No Abstract]   [Full Text] [Related]  

  • 15. [Electrical rhythms of the brain following administration of mescaline and lysergic acid (LSD 25) in mental disorders].
    SANGUINETI I; NEGRI VU; LARICCHIA R
    Riv Sper Freniatr Med Leg Alien Ment; 1955 Dec; 79(4):771-97. PubMed ID: 13311367
    [No Abstract]   [Full Text] [Related]  

  • 16. MMPI score changes induced by lysergic acid diethylamide (LSD-25).
    BELLEVILLE RE
    J Clin Psychol; 1956 Jul; 12(3):279-82. PubMed ID: 13332097
    [No Abstract]   [Full Text] [Related]  

  • 17. [First trials of psychopharmacological antagonism; experimental psychoses induced with d-lysergic acid diethylamide and treated with chlorpromazine and reserpine].
    GIBERTI F; GREGORETTI L
    Sist Nerv; 1955; 7(4):301-10. PubMed ID: 13290891
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychophysiological investigations in experimental psychoses; results of the exhibition of d-lysergic acid diethylamide to psychiatric patients.
    SLOANE B; DOUST JW
    J Ment Sci; 1954 Jan; 100(418):129-44. PubMed ID: 13152528
    [No Abstract]   [Full Text] [Related]  

  • 19. Brom-lysergic acid diethylamide: a highly potent serotonin antagonist.
    SOLLERO L; PAGE IH; SALMOIRAGHI GC
    J Pharmacol Exp Ther; 1956 May; 117(1):10-5. PubMed ID: 13320295
    [No Abstract]   [Full Text] [Related]  

  • 20. LSD-like delirium following ingestion of a small amount of its brom analog (BOL-148).
    RICHARDS N; CHAPMAN LF; GOODELL H; WOLFF HG
    Ann Intern Med; 1958 May; 48(5):1078-82. PubMed ID: 13534225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.